Standout Papers
Citation Impact
Citing Papers
Probing mucin-type O-linked glycosylation in living animals
2006 StandoutNobel
The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins
2019 StandoutNobel
High burden and pervasive positive selection of somatic mutations in normal human skin
2015 StandoutScience
An enzymatic toolkit for selective proteolysis, detection, and visualization of mucin-domain glycoproteins
2020 StandoutNobel
MUC1 Vaccine for Individuals with Advanced Adenoma of the Colon: A Cancer Immunoprevention Feasibility Study
2012
Scientific Utopia
2012 Standout
Autocrine Production of Amphiregulin Predicts Sensitivity to Both Gefitinib and Cetuximab in EGFR Wild-type Cancers
2008
In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody.
2000
Comprehensive genomic characterization of head and neck squamous cell carcinomas
2015 StandoutNature
Estimating the reproducibility of psychological science
2015 StandoutScience
Hallmarks of Cancer: The Next Generation
2011 Standout
Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules
2003
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
ErbB-targeted therapeutic approaches in human cancer
2003
Eukaryotic nucleotide excision repair: from understanding mechanisms to influencing biology
2008
Stromal fibroblasts in cancer initiation and progression
2004 StandoutNature
Retinoic acid receptors: From molecular mechanisms to cancer therapy
2014
Repopulation of cancer cells during therapy: an important cause of treatment failure
2005
mRNA Is an Endogenous Ligand for Toll-like Receptor 3
2004 StandoutNobel
Novel mutant-selective EGFR kinase inhibitors against EGFR T790M
2009 StandoutNature
Epidermal growth factor receptor and response of head-and-neck carcinoma to therapy
2004
Therapeutic uses of vitamin D analogues
2001
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
2008 Standout
Head and neck cancer
2008 Standout
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
The resurgence of platinum-based cancer chemotherapy
2007 Standout
Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression
2004
Vitamin D Deficiency
2007 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Scientific method: Statistical errors
2014 StandoutNature
Regulation of nucleotide excision repair activity by transcriptional and post-transcriptional control of the XPA protein
2010 StandoutNobel
Cancer immunoediting from immune surveillance to immune escape
2007
PRAD-1 (CCND1)/Cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma
1994
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
2009 Standout
Glycans in cancer and inflammation — potential for therapeutics and diagnostics
2005 StandoutNobel
The biology of the P-glycoproteins
1995
Inflammatory cell infiltration of tumors: Jekyll or Hyde
2007
Immune infiltration in human tumors: a prognostic factor that should not be ignored
2009
Cellular processing of platinum anticancer drugs
2005 Standout
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Progression-free rate as the principal end-point for phase II trials in soft-tissue sarcomas
2002
Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF‐κB and AP‐1 activation and IL‐8 and VEGF expression in human head and neck squamous cell carcinoma lines
2002
Immunity, Inflammation, and Cancer
2010 Standout
Sentinel Lymph Node Radiolocalization in Head and Neck Squamous Cell Carcinoma
2000
Head and neck cancer as a clinical model for molecular targeting of therapy: combining EGFR blockade with radiation
2001
Glycoproteomic Analysis of Prostate Cancer Tissues by SWATH Mass Spectrometry Discovers N-acylethanolamine Acid Amidase and Protein Tyrosine Kinase 7 as Signatures for Tumor Aggressiveness
2014
Therapies Directed Against Epidermal Growth Factor Receptor in Aerodigestive Carcinomas
2007
Inflammation and necrosis promote tumour growth
2004
The tumor microenvironment and its role in promoting tumor growth
2008 Standout
Repeatability of published microarray gene expression analyses
2009
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 Standout
Elevation of XPA protein level in testis tumor cells without increasing resistance to cisplatin or UV radiation
2008
The sweet and sour of cancer: glycans as novel therapeutic targets
2005
Cancer vaccines and carbohydrate epitopes
2011
Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
2008 Standout
Angiogenesis as a therapeutic target
2005 StandoutNature
Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors
2002
Genetic Alterations of Cyclins, Cyclin-Dependent Kinases, and Cdk Inhibitors in Human Cancer
1996
Development of a Novel Method for Analyzing Collagen O-glycosylations by Hydrazide Chemistry
2012
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
2004 Standout
Head and Neck Cancer
2001 Standout
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 Standout
Hierarchical Assembly of Model Cell Surfaces: Synthesis of Mucin Mimetic Polymers and Their Display on Supported Bilayers
2007 StandoutNobel
Growth factor involvement in progression of prostate cancer
1998
Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis
2011 StandoutNobel
Phase II Multicenter Study of the Epidermal Growth Factor Receptor Antibody Cetuximab and Cisplatin for Recurrent and Refractory Squamous Cell Carcinoma of the Head and Neck
2005
Tumor-Associated Tn-MUC1 Glycoform Is Internalized through the Macrophage Galactose-Type C-Type Lectin and Delivered to the HLA Class I and II Compartments in Dendritic Cells
2007
Selective Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ZD1839 Is Generally Well-Tolerated and Has Activity in Non–Small-Cell Lung Cancer and Other Solid Tumors: Results of a Phase I Trial
2002
Structure of the STRA6 receptor for retinol uptake
2016 StandoutScienceNobel
Density Variant Glycan Microarray for Evaluating Cross-Linking of Mucin-like Glycoconjugates by Lectins
2012 StandoutNobel
Enhanced apoptosis with combination C225/radiation treatment serves as the impetus for clinical investigation in head and neck cancers.
2000
Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck.
1999
Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.
2002
Concurrent Cetuximab, Cisplatin, and Concomitant Boost Radiotherapy for Locoregionally Advanced, Squamous Cell Head and Neck Cancer: A Pilot Phase II Study of a New Combined-Modality Paradigm
2006
Science of science
2018 StandoutScience
Monoclonal antibody to an external epitope of the human mdr1 P-glycoprotein.
1993
Cancer Cell Cycles
1996 StandoutScience
Growth factor involvement in progression of prostate cancer.
1998
Molecular Pathology of Head and Neck Cancer: Implications for Diagnosis, Prognosis, and Treatment
2008
Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction.
2002
Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model
2012 StandoutNobel
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
2003 StandoutNobel
Reproducible Research in Computational Science
2011 StandoutScience
cis -Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects
2008 StandoutNobel
The Expanding Role of Systemic Therapy in Head and Neck Cancer
2004
Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
2001
Quantitative measurements of N ‐linked glycoproteins in human plasma by SWATH ‐MS
2013
A Chemical Reporter Strategy to Probe Glycoprotein Fucosylation
2006 StandoutNobel
Multicenter Phase II Study of Erlotinib, an Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck
2003
Cancer Genome Landscapes
2013 StandoutScience
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Defining Glycoprotein Cancer Biomarkers By MS in Conjunction With Glycoprotein Enrichment
2015
A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels
1998 StandoutNobel
Imaging the glycome
2008 StandoutNobel
Immune suppression in cancer: Effects on immune cells, mechanisms and future therapeutic intervention
2005
Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma.
2002 Standout
Status of Epidermal Growth Factor Receptor Antagonists in the Biology and Treatment of Cancer
2003
Prognostic Significance of Vascular Endothelial Growth Factor Protein Levels in Oral and Oropharyngeal Squamous Cell Carcinoma
2000
Direct Cellular Responses to Platinum-Induced DNA Damage
2007
Circadian control of XPA and excision repair of cisplatin-DNA damage by cryptochrome and HERC2 ubiquitin ligase
2010 StandoutNobel
Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors
2002
Noncalcemic Actions of Vitamin D Receptor Ligands
2005
Phase I Study of Anti–Epidermal Growth Factor Receptor Antibody Cetuximab in Combination With Radiation Therapy in Patients With Advanced Head and Neck Cancer
2001
Shining Light into Black Boxes
2012 StandoutScienceNobel
Mutant Epidermal Growth Factor Receptor (EGFRvIII) Contributes to Head and Neck Cancer Growth and Resistance to EGFR Targeting
2006
Clinical significance of decreased zeta chain expression in peripheral blood lymphocytes of patients with head and neck cancer.
1999
Factors affecting number of citations: a comprehensive review of the literature
2016 Standout
Phase II Multicenter Study of the Antiepidermal Growth Factor Receptor Monoclonal Antibody Cetuximab in Combination With Platinum-Based Chemotherapy in Patients With Platinum-Refractory Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck
2005
Chemical Glycoproteomics
2016 StandoutNobel
Promoting Transparency in Social Science Research
2014 StandoutScienceNobel
Quantitative mass spectrometric analysis of glycoproteins combined with enrichment methods
2014
Works of Roger Day being referenced
Sharing Detailed Research Data Is Associated with Increased Citation Rate
2007
MDR1 transcript levels as an indication of resistant disease in acute myelogenous leukaemia
1990
A phase II trial of all- trans -retinoic acid in hormone-refractory prostate cancer: a clinical trial with detailed pharmacokinetic analysis
1997
Phase II trial of oral 1,25-dihydroxyvitamin D (calcitriol) in hormone refractory prostate cancer
1995
Calculation of lytic units for the expression of cell-mediated cytotoxicity
1992
Vitamin d inhibition of prostate adenocarcinoma growth and metastasis in the dunning rat prostate model system
1997
Gene Amplification and Gene Dosage in Cell Lines Derived From Squamous Cell Carcinoma of the Head and Neck
1991
Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancer
2004
Lymphatic Mapping With Isosulfan Blue Dye in Squamous Cell Carcinoma of the Head and Neck
1998
Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient Survival
1998 Standout
Reduced levels of XPA, ERCC1 and XPF DNA repair proteins in testis tumor cell lines
2004
The number of intratumoral dendritic cells and ?-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma
2001
Incorporating Toxicity Considerations Into the Design of Two-Stage Phase II Clinical Trials
1995
Analysis of therapeutic and immunologic effects of R24 anti-GD3 monoclonal antibody in 37 patients with metastatic melanoma
2000
Lung Cancer Serum Biomarker Discovery Using Glycoprotein Capture and Liquid Chromatography Mass Spectrometry
2010
Absent or low expression of the zeta chain in T cells at the tumor site correlates with poor survival in patients with oral carcinoma.
1998
Carmustine and streptozocin in refractory melanoma: an attempt at modulation of O-alkylguanine-DNA-alkyltransferase.
1996